[Physiopathologic significance of the radioimmunologic determination of human kininogens].
We quantify total and high molecular weight kininogens by radioimmunoassay. The main characteristic of these molecules is the release of kinins. In this paper we would compare the antigenicity of kininogens with their pharmacological property.
Adam
A
A
Damas
J
J
Ers
P
P
Albert
A
A
Stas
J L
JL
Lecomte
J
J
D000818:Animals; D001920:Bradykinin / Q000097:blood / Q000378:metabolism; D016264:Dextran Sulfate; D003911:Dextrans / Q000494:pharmacology; D006801:Humans; D066298:In Vitro Techniques; D007610:Kallikreins / Q000494:pharmacology; D007704:Kininogens / Q000097:blood* / Q000172:deficiency / Q000276:immunology; D007705:Kinins / Q000097:blood / Q000378:metabolism*; D008970:Molecular Weight; D011863:Radioimmunoassay; D051381:Rats; D014357:Trypsin / Q000378:metabolism
D003911:Dextrans; D007704:Kininogens; D007705:Kinins; D016264:Dextran Sulfate; D007610:Kallikreins; D014357:Trypsin; D001920:Bradykinin
Signification physiopathologique des dosages radioimunologiques des kininogènes humains.